Clinical Trial Update: Effects of DPP4 Inhibition on COVID-19 [Phase 4]

View source ↗

Summary

A Phase 4 trial examining the effects of DPP-4 inhibition on COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Miami | Conditions: Coronavirus Infection, Type 2 Diabetes | Phase 4 | Status: WITHDRAWN